oxy update out - stay tuned, page-83

Is a slight delay in phase III to allow catch up for oxymorphone single and multi-dose trials.

You'd have to think that is the case. It was stated a long time ago, at the AGM in fact that they believed crystallisation issues were behind them and many of us assumed because of delays in updating us that maybe they weren't telling us all and there were continued crystallisation issues. Well it does appear we were right, they weren't telling us all, but it was for a very different reason.

I'm still flabbergasted at the current share price action considering yesterday's announcement. I can understand why nervous nellies like playez are looking for plausible explanations. Maybe it's as simple as investors needing to see the dollar signs in writing. If so, I'm not expecting they'll need to wait too much longer.